bethanechol has been researched along with Esophagitis in 3 studies
Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.
Esophagitis: INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a double-blind study to compare the effectiveness of oral bethanechol chloride or cimetidine in treating reflux esophagitis to evaluate the drugs' effects on the symptoms of esophagitis and its verification by endoscopy." | 7.66 | Bethanechol or cimetidine in the treatment of symptomatic reflux esophagitis: a double-blind control study. ( Chey, WY; Hamilton, D; Nadelson, N; Shak, A; Thanik, K, 1982) |
| "In the presence of esophagitis (1) resting lower esophageal sphincter pressure decreased; (2) the excitatory response to bethanechol was maintained; (3) there was a reduction in the excitatory response to McNeil-A343 and cholecystokinin at the highest dosages; (4) there was an increase in the potency of cholecystokinin and McNeil-A343 to produce an inhibitory response; (5) the inhibitory response to intraesophageal balloon distension was maintained; and (6) increased inhibitory responses took longer to normalize than the reduced excitatory responses." | 3.68 | Assessment of neural inhibition of the lower esophageal sphincter in cats with esophagitis. ( Diamant, NE; Salapatek, AM, 1993) |
| "We conducted a double-blind study to compare the effectiveness of oral bethanechol chloride or cimetidine in treating reflux esophagitis to evaluate the drugs' effects on the symptoms of esophagitis and its verification by endoscopy." | 3.66 | Bethanechol or cimetidine in the treatment of symptomatic reflux esophagitis: a double-blind control study. ( Chey, WY; Hamilton, D; Nadelson, N; Shak, A; Thanik, K, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thanik, K | 1 |
| Chey, WY | 1 |
| Shak, A | 1 |
| Hamilton, D | 1 |
| Nadelson, N | 1 |
| Turton, DB | 1 |
| Shakir, KM | 1 |
| Salapatek, AM | 1 |
| Diamant, NE | 1 |
3 other studies available for bethanechol and Esophagitis
| Article | Year |
|---|---|
Bethanechol or cimetidine in the treatment of symptomatic reflux esophagitis: a double-blind control study.
Topics: Administration, Oral; Bethanechol; Bethanechol Compounds; Cimetidine; Double-Blind Method; Endoscopy | 1982 |
Galactorrhea caused by esophagitis.
Topics: Adult; Anti-Ulcer Agents; Bethanechol; Esophagitis; Famotidine; Female; Galactorrhea; Gastroesophage | 1995 |
Assessment of neural inhibition of the lower esophageal sphincter in cats with esophagitis.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Acute Disease; Animals; Bethan | 1993 |